# Immunomodulatory Effects of NB-UVB and Steroids in Vitiligo: A Study on CXCL11 and TEMRA Biomarkers

> **NCT06946069** · NA · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 40 (estimated)

## Conditions studied

- Vitiligo
- NB-UVB

## Interventions

- **RADIATION:** NB-UVB twice weekly
- **OTHER:** NB-UVB + dexamethasone (2.5-3 mg/week)

## Key facts

- **NCT ID:** NCT06946069
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06946069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06946069, "Immunomodulatory Effects of NB-UVB and Steroids in Vitiligo: A Study on CXCL11 and TEMRA Biomarkers". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT06946069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*